Agilent Technologies Inc banner

Agilent Technologies Inc
XMUN:AG8

Watchlist Manager
Agilent Technologies Inc Logo
Agilent Technologies Inc
XMUN:AG8
Watchlist
Price: 116.35 EUR -2.72%
Market Cap: €34.1B

Agilent Technologies Inc
Investor Relations

Agilent Technologies makes the tools that scientists and lab technicians use to test, measure, and analyze samples. Its products include analytical instruments, lab software, consumables, and repair and support services. Customers use them in drug development, clinical and diagnostic labs, food safety, environmental testing, and chemical research. The company sells equipment such as chromatography and spectroscopy systems, along with the parts and chemicals that those systems need to keep running. It also earns money from service contracts, maintenance, and replacement consumables, which creates repeat business after the initial sale. A large part of Agilent’s revenue comes from labs that need reliable instruments and ongoing support rather than one-time purchases. Agilent sits in the middle of the scientific testing value chain: it does not usually discover the medicines or run the labs, but it provides the core tools those customers depend on. That makes its business different from many industrial companies because demand is tied to long-running needs for testing, quality control, and research rather than a single end product.

Show more
Loading...
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q2 2026
Call Date
May 27, 2026
AI Summary
Q2 2026

Beat and raise: Agilent said Q2 revenue, margin and EPS all came in above the high end of guidance, and it raised full-year revenue and EPS outlooks.

Strong execution: Management credited the quarter to Ignite operating system gains, pricing, productivity improvements, and better commercial execution across the business.

Broad demand: Pharma, chemicals and advanced materials, diagnostics and clinical, and forensics all performed well, while food and academia/government were weaker.

Instruments strong: Instrument orders again met or exceeded revenue, marking the ninth straight quarter of book-to-bill at or above 1, helped by replacement cycles and share gains.

Guidance up: Full-year core revenue growth guidance moved to 4.5% to 6%, EPS to $6 to $6.10, and operating margin expansion to 85 basis points at the midpoint.

Watch points: Management flagged softer food demand, pressure from the Middle East conflict, and China weakness in academia/government and food, but said the business remains stable overall.

Key Financials
Revenue
$1.83 billion
EPS
$1.49
Operating margin
26.4%
Gross margin
55%
Pharma growth
6%
Chemicals and advanced materials growth
8%
Diagnostics and clinical growth
11%
Environmental and forensics growth
13%
Food growth
-3%
Academia and government growth
-5%
AMG growth
11%
LDG growth
9%
ACG growth
2%
China growth
-9%
Operating cash flow
$277 million
Capital expenditures
$76 million
Net leverage ratio
0.7 turns
Diluted shares outstanding
283 million
Tax rate
14.5%
Other income
$11 million
Pricing
approximately 200 basis points
Earnings Call Recording
Other Earnings Calls

Management

Mr. Rodney Gonsalves
Principal Accounting Officer, VP & Corporate Controller

Rodney Gonsalves is the Vice President and Chief Accounting Officer at Agilent Technologies Inc. He specializes in finance and accounting functions, including financial reporting, auditing, and compliance. Gonsalves has extensive experience in leading and managing finance teams, focusing on delivering financial insights and maintaining rigorous standards of accuracy and efficiency. He plays a critical role in Agilent Technologies' financial health, ensuring that all accounting practices adhere to the highest standards and regulations. Prior to his role at Agilent, he gathered substantial experience in varied finance roles across different organizations, contributing significantly to strategic financial planning and execution.

Mr. John Kohl
Senior Vice President & Chief Information Officer

John Kohl is the Senior Vice President, General Counsel, and Secretary at Agilent Technologies, Inc. He plays a pivotal role in overseeing the global legal affairs of the company, providing strategic guidance on legal, regulatory, and compliance matters. Kohl has been instrumental in shaping and navigating Agilent's legal strategies and policies, ensuring adherence to increasing regulatory requirements across various markets. With a robust legal background and significant experience in the technology and healthcare sectors, John Kohl has contributed to Agilent's growth and success in the industry. His leadership extends beyond legal counsel, as he participates in key executive decisions, corporate governance, and risk management initiatives. Kohl joined Agilent Technologies with a wealth of experience gained from his previous roles in prestigious law firms and other corporations. His expertise spans various areas, including intellectual property, mergers and acquisitions, and legal risk management, making him a valuable asset to Agilent's executive team.

Mr. Bret M. DiMarco
Senior VP, Chief Legal Officer, & Secretary

Bret M. DiMarco serves as the Senior Vice President, General Counsel, and Secretary of Agilent Technologies Inc. In his role, DiMarco oversees Agilent's global legal, intellectual property, and compliance functions. He plays a critical role in guiding the company through complex legal landscapes, ensuring compliance with regulations, and protecting Agilent's intellectual property assets. DiMarco's leadership is instrumental in supporting Agilent's business goals and maintaining its ethical standards across its global operations. His extensive experience and expertise in legal affairs contribute significantly to the company's strategic initiatives and growth.

Mr. Dominique P. Grau
Senior Vice President of Human Resources & Global Communications

Dominique P. Grau is a notable executive at Agilent Technologies Inc. He serves as the Senior Vice President of Quality and Regulatory Affairs for the company. In his role, he oversees global quality assurance, regulatory affairs, and compliance functions. His responsibilities include ensuring that Agilent’s products adhere to the highest quality standards and meet regulatory requirements across different markets. Mr. Grau has extensive experience in quality and regulatory roles, contributing significantly to the life sciences and diagnostics sectors. His expertise is integral to maintaining Agilent's reputation for excellence in providing trusted analytical solutions and ensuring the company’s products contribute to customer success. In addition to his current role, Dominique P. Grau's career includes various leadership positions, where he has demonstrated his adeptness at managing complex regulatory landscapes and driving improvement initiatives. His educational background and career trajectory underline his commitment to quality and compliance, positioning him as a key figure in Agilent's leadership team.

Ms. Yvonne Mackie
MD of UK & Ireland Operations and VP of Human Resources - Europe
No Bio Available
Ms. Jenipher E. Dalton
Senior VP, Chief Quality & Regulatory Officer

Jenipher E. Dalton is an executive at Agilent Technologies Inc., where she holds the position of Vice President, Assistant General Counsel, and Assistant Secretary. In her role, Dalton plays a crucial part in overseeing legal matters and corporate governance at Agilent, a leading global company in the life sciences, diagnostics, and applied chemical markets. Her responsibilities typically involve managing legal risks, supporting business strategies, providing legal guidance on transactions, and ensuring regulatory compliance. Through her expertise and leadership, Dalton contributes to Agilent’s mission of advancing the quality of life by providing cutting-edge technology solutions.

Mr. Philip Binns
Senior VP of Agilent and President of Life Sciences & Applied Markets Group

Philip Binns is recognized for his role at Agilent Technologies, where he has made significant contributions. Serving as Senior Vice President, he oversees the Chemical & Energy, Food, and Pharma business unit in the company's Life Sciences and Applied Markets Group. Under his leadership, these sectors have successfully advanced in developing and deploying innovative solutions that meet varied industry needs. Binns' strategic insights and management acumen have played a crucial role in navigating complex market landscapes and expanding Agilent's position within these critical industries. His extensive experience in technology and market strategy continues to serve as a valuable asset to Agilent Technologies.

Ms. Angelica Riemann III
Senior Vice President
No Bio Available
Dr. Simon May
SVP of Agilent & President of Diagnostics & Genomics Group

Dr. Simon May is a prominent figure at Agilent Technologies Inc., where he holds a significant leadership role. As of the latest information, he serves as the Vice President and General Manager of the Mass Spectrometry Division. Dr. May is responsible for overseeing the strategic direction, development, and global operations of Agilent’s mass spectrometry business, a core area within the life sciences and applied markets. With a strong academic background in chemistry, Dr. May has extensive expertise in analytical instrumentation, having garnered numerous years of experience in the field. Before joining Agilent, he held various roles that contributed to his deep understanding of scientific research and development, as well as business management. Throughout his career at Agilent, Dr. May has been instrumental in driving innovation and advancing the company’s technological capabilities in mass spectrometry. His leadership has been key to enhancing Agilent's position as a leader in providing solutions for complex analytical challenges across various industries, including pharmaceuticals, environmental, and food safety sectors. Dr. May's contributions are recognized within the scientific community and industry, noted for his commitment to promoting scientific excellence and fostering collaborative relationships to advance the capabilities and applications of mass spectrometry technologies.

Contacts

Address
CALIFORNIA
Santa Clara
5301 Stevens Creek Blvd
Contacts
+14083458886.0
www.agilent.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett